Intarcia Therapeutics, Inc. operates as a biopharmaceutical company that develops therapies for the prevention and management of serious chronic diseases. It is developing product candidates using the Medici Drug Delivery System, a technology platform that merge medicine with technology to treat typ...
Intarcia Therapeutics, Inc. operates as a biopharmaceutical company that develops therapies for the prevention and management of serious chronic diseases. It is developing product candidates using the Medici Drug Delivery System, a technology platform that merge medicine with technology to treat type 1 and 2 diabetes, obesity, nonalcoholic steatohepatitis, and HIV. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics, Inc. was incorporated in 1995 and is headquartered in Boston, Massachusetts.
Mehr anzeigen